Aurora extends its hand to the Danish farmers for medical cannabis


A tomato farm near Odense is to establish the largest grower of medicinal cannabis in Europe in a joint venture with Canadian company Aurora.

From 2018, Danish companies are permitted to grow medicinal cannabis.

Mads Pedersen, described in Denmark as a ‘tomato king’, last week announced that his company, Alfred Pedersen & Søn, would be putting considerable resources into the crop in a joint venture with Aurora.

The production facility will be located near the town of Odense and ready to begin operating next year. 

Peru legalises medical marijuana in move spurred by mother's home lab


Lawmakers in Peru have voted overwhelmingly in favour of a bill to legalise medical marijuana, allowing cannabis oil to be locally produced, imported and sold.

With a vote of 68-5, Peru’s Congress approved the bill which will be written into law in 60 days, once regulations for producing and selling cannabis have been set out.

Ahead of this week's vote, pro-government lawmaker Alberto de Belaunde said: "Science is on our side, the regional current is on our side, let's not let our fears paralyse us."

Medical cannabis makes small steps in EU. Italy Suffers from the serious medical cannabis shortage.


As of 1 January, Denmark now allows the use of medical cannabis for patients suffering from various illnesses.

The four year-trial was authorised on 18 December by the parliament in Copenhagen, in a move which also licensed some companies to grow and produce the drug in the Scandinavian country.

Capsules, cannabis extract as a mouth spray, and dried cannabis flowers for vaporising or teas are the main authorised medicines in the EU, a 2017 report by the European Monitoring Centre for Drug and Addiction (EMCDDA) states.

By contrast, no country authorises the smoking of cannabis for medical purposes – given the risks that smoking poses to health, especially if combined with tobacco.

In the EU, only Austria, the Czech Republic, Finland, Germany, Italy, Portugal, Poland and Spain currently authorise marijuana's use as a medicine - while a few other states are planning legislation on the issue.

In fact, Italy is currently experiencing a serious medical cannabis shortage, since not enough marijuana plants for medical use are grown, patients and NGOs report.

Patients had to resort to the "black market and self-cultivation" as a result of the shortage, the Italian Association for Civil Liberty & Rights (CILD) reported in December.

To tackle the lack of plants, the Italian ministry of defence (responsible for the secure growing of medicinal cannabis) was forced to look abroad to buy some 100 kilos of marijuana in November.

Hear Andy's story. A journey from an ADHD patient to a successful Gardner. thanks to cannabis.


When Andy McConville suffered a mental health crisis he realised he could put his green fingers to better use.

Andy McConville has landed his dream job - and he owes it all to the fact he used to be a cannabis farmer.

The 34-year-old horticultural specialist spent a decade growing weed for his own use at home.

It was only when he suffered a mental health crisis about three years ago that he realised he could put his green fingers to better use.

He initially began smoking cannabis to help him cope with the symptoms of what he now knows is ADHD.

But after a while his drug use began to take its toll.

Andy estimates that he’s had between 250 to 280 jobs since he left school at the age of 15. He got his first job working for a plasterboard company, and has had scores of trade jobs ever since, from being a plumber, to joiner, fork lift driver to warehouse assistant. He’s also worked at an ice cream factory, which he said was great for getting free choc ices for lunch, and has been employed as a dog walker.

Following his diagnosis Andy, who grew up in Tameside, decided to put his gardening skills to good use.

“He asked me what I enjoyed doing most and I said ‘growing’. It was a weird thing, I stumbled on it myself, but I knew straight away that’s where I found peace.”

He enrolled on a horticultural course at Hopwood Hall College in Rochdale, and began volunteering at a community allotment run by homeless charity Petrus in the town.

And he now works at Todmorden Incredible Aqua Garden - a state-of-the-art hydroponics, aquaponics and permaculture garden centre.

Watch his full interview on the link given below to know it word by word for a better future. 


GD Pharma becomes first company in South Australia to begin cannabis extractions


An Adelaide company is to become the first in South Australia to begin cannabis extractions and create market-ready products from a secret laboratory in the city.

GD Pharma has been importing cannabis components from overseas but under its new manufacturing licence it will be able to import the plants, extract the chemicals, and produce a range of experimental prescription products.

Chief executive Antony Condina said it meant they could control the concentration of cannabis to create tailor-made products for a wide range of clients.

Some 266 patients are approved to use medicinal cannabis Australia-wide.

He said the main hurdle to achieve the manufacturing license was the risk of cannabis being shifted into the black market, including risks of theft and being "held up".

GD Pharma's secret new factory will operate by the end of year and would take about one week to produce a batch of diluted resin that costs about $500 for a bottle.

Mr Condina said they were unlikely to draw a profit because red tape restricted doctors' ability to prescribe cannabis.

"Last year it was estimated about 100,000 Australians would benefit from medicinal cannabis but, in reality, there's only been around 100 patients in 11 months who have been approved for products."

Proponents say there is evidence to suggest cannabis products can help with conditions like multiple sclerosis, severe intractable epilepsy in children, intractable nausea and vomiting due to chemotherapy.

Those opposing it, however, along with the Federal Department of Health, have cited a lack of quality research along with ongoing investigations and trials as the reason for restrictions.

The first marijuana crop in Maryland is ready but still, not available for sale. Know why!!


The first crop in Maryland’s long-delayed medical cannabis program is mature and waiting for testing, but it is still unclear when patients might be able to buy it.

And industry officials caution that when it is ready for sale, there will not be nearly enough to meet market demand.

The nascent industry has grown in fits and starts, beset by delays, court cases and a complete overhaul of the commission this summer.

On Tuesday afternoon, regulators approved eight more firms to enter the market — one grower, four processors, two independent testing labs and two dispensaries.

ForwardGro, the Anne Arundel County company that was the first in the state to get a growing license, sent its product to the lab last month and is waiting.

ForwardGro spokeswoman Gail Rand said her company gave the testing lab some of its product to help the facility calibrate its machines, a process that is still underway. That must be completed before the marijuana flowers are tested for potency and quality, then certified for sale. She could not estimate when that would happen.

Newly approved dispensary owner William Askinazi said he’s hoping to have at least some product in two to four weeks.

The medical marijuana commission granted him permission Tuesday to open the doors at Potomac Holistics, his 3,000-square-foot medical suite near Shady Grove Medical Center in Montgomery County. In addition to dispensing at its office space, Potomac Holistic plans to deliver cannabis to patients all over the state.

There is not a public list of doctors available, so patients must seek out professionals to recommend it. Doctors, dentists, nurse practitioners and midwives can recommend the medicine.

During a meeting of the cannabis commission held in the Frederick County Council chambers, Jameson cautioned that the whole supply chain won’t be up and running at once, and patients may need to wait.

"Cannabis saved my daughter's life", Says the mother of a 6 year old in Aston Villa


Footballer Gabby Agbonlahor's six-year-old niece Jayla is the UK's youngest legally approved Class B drug user. 

The parents of a young brain-damaged girl who once faced regular seizures have credited cannabis oil with saving their daughter's life.


Six-year-old Jayla Agbonlahor, whose father Charisma is the brother of Aston Villa star Gabby, was rushed to the hospital just days after her first birthday when she mysteriously stopped breathing.

Doctors have been unable to diagnose exactly what happened to the young girl, who was left unable to walk, talk, eat or drink and wracked by regular seizures after the attack.

Mum Louise Bostock tried everything to help her little girl, from medication to having her blessed in the holy water at Lourdes.


When medics at Birmingham Children's Hospital told her that Jayla was resistant to conventional medication she turned to cannabis oil in desperation and was amazed to see it helping her daughter.

Despite initially being summoned to safeguarding meetings over its use, Louise fought for the right to treat Jayla with the plant and says Jayla is now the UK's youngest legally approved Class B drug user.

Louise, 33, stumbled across articles proclaiming the alleged medical benefits of cannabis oil when Jayla was four-years-old and started a quest to source the drug in secret.

Once she began administering it to her daughter she noticed a real change, with Jayla beginning to smile and eat properly and even facing fewer seizures.


But when she admitted to nurses that she was using cannabis oil she was immediately summoned to a meeting with police and council officials.

Louise was given clearance to use the drug in 2015. However, she still cannot obtain it through prescription and is forced to buy cannabis packages from Holland, with a £80 order lasting around one month.

Louise now wants to see the NHS approving the use of the drug for patients of all ages, and particularly children like Jayla who suffer through prolonged pain.